Click here to get full coverage on Enterprise value to revenue forward of SMS Pharmaceuticals Limited – NSE:SMSPHARMA - TradingView

Enterprise value to revenue forward of SMS Pharmaceuticals Limited – NSE:SMSPHARMA  TradingView

Enterprise value to revenue forward of SMS Pharmaceuticals Limited – NSE:SMSPHARMA - TradingView

Click here to get full coverage on SMS Pharmaceuticals' (NSE:SMSPHARMA) Earnings Are Of Questionable Quality - simplywall.st

SMS Pharmaceuticals' (NSE:SMSPHARMA) Earnings Are Of Questionable Quality  simplywall.st

SMS Pharmaceuticals' (NSE:SMSPHARMA) Earnings Are Of Questionable Quality - simplywall.st

Click here to get full coverage on SMS Pharma Q4 Net Profit Climbs to ₹20.9 Cr with 1.4% YoY Growth - Sahi

SMS Pharma Q4 Net Profit Climbs to ₹20.9 Cr with 1.4% YoY Growth  Sahi

SMS Pharma Q4 Net Profit Climbs to ₹20.9 Cr with 1.4% YoY Growth - Sahi

Click here to get full coverage on SMS Pharma up 8% as arm gets USFDA nod for reformulated Ranitidine tablets - Business Standard

SMS Pharma up 8% as arm gets USFDA nod for reformulated Ranitidine tablets  Business Standard

SMS Pharma up 8% as arm gets USFDA nod for reformulated Ranitidine tablets - Business Standard

Click here to get full coverage on Fraudsters Used Fake Documents to Sell SMS Pharma Shares Worth Rs 3.31 Crore, Probe On - Medical Dialogues

Fraudsters Used Fake Documents to Sell SMS Pharma Shares Worth Rs 3.31 Crore, Probe On  Medical Dialogues

Fraudsters Used Fake Documents to Sell SMS Pharma Shares Worth Rs 3.31 Crore, Probe On - Medical Dialogues

Click here to get full coverage on SMS Pharma gains 18% on U.S FDA nod for reformulated Ranitidine of associate firm - The Hindu

SMS Pharma gains 18% on U.S FDA nod for reformulated Ranitidine of associate firm  The Hindu

SMS Pharma gains 18% on U.S FDA nod for reformulated Ranitidine of associate firm - The Hindu

Click here to get full coverage on SMS Pharma FY26 PAT rises 48% to ₹102 Cr; margins expand - scanx.trade

SMS Pharma FY26 PAT rises 48% to ₹102 Cr; margins expand  scanx.trade

SMS Pharma FY26 PAT rises 48% to ₹102 Cr; margins expand - scanx.trade

Click here to get full coverage on With EPS Growth And More, SMS Pharmaceuticals (NSE:SMSPHARMA) Makes An Interesting Case - simplywall.st

With EPS Growth And More, SMS Pharmaceuticals (NSE:SMSPHARMA) Makes An Interesting Case  simplywall.st

With EPS Growth And More, SMS Pharmaceuticals (NSE:SMSPHARMA) Makes An Interesting Case - simplywall.st

Click here to get full coverage on FDA completes inspection of SMS Pharma’s Vizag facility - Indian Pharma Post

FDA completes inspection of SMS Pharma’s Vizag facility  Indian Pharma Post

FDA completes inspection of SMS Pharma’s Vizag facility - Indian Pharma Post

Click here to get full coverage on SMS Pharma Shares Skyrocketed 17% as Arm Secured USFDA Approval - Equitypandit

SMS Pharma Shares Skyrocketed 17% as Arm Secured USFDA Approval  Equitypandit

SMS Pharma Shares Skyrocketed 17% as Arm Secured USFDA Approval - Equitypandit

Click here to get full coverage on Buzzing Stocks: Drugmaker gains most in five years after regulator approves re-entry of key drug - CNBC TV18

Buzzing Stocks: Drugmaker gains most in five years after regulator approves re-entry of key drug  CNBC TV18

Buzzing Stocks: Drugmaker gains most in five years after regulator approves re-entry of key drug - CNBC TV18

Click here to get full coverage on SMS Pharma Surges 10% on USFDA Nod, Ends 3.85% Lower - HDFC Sky

SMS Pharma Surges 10% on USFDA Nod, Ends 3.85% Lower  HDFC Sky

SMS Pharma Surges 10% on USFDA Nod, Ends 3.85% Lower - HDFC Sky

Click here to get full coverage on Market Participants Recognise SMS Pharmaceuticals Limited's (NSE:SMSPHARMA) Earnings Pushing Shares 31% Higher - simplywall.st

Market Participants Recognise SMS Pharmaceuticals Limited's (NSE:SMSPHARMA) Earnings Pushing Shares 31% Higher  simplywall.st

Market Participants Recognise SMS Pharmaceuticals Limited's (NSE:SMSPHARMA) Earnings Pushing Shares 31% Higher - simplywall.st

Click here to get full coverage on SMS Pharma Faces Rs 7.19 Crore Tax Demand in Income Under-Reporting Case - Medical Dialogues

SMS Pharma Faces Rs 7.19 Crore Tax Demand in Income Under-Reporting Case  Medical Dialogues

SMS Pharma Faces Rs 7.19 Crore Tax Demand in Income Under-Reporting Case - Medical Dialogues

Click here to get full coverage on SMS Pharmaceuticals (NSE:SMSPHARMA) Has Announced A Dividend Of ₹0.40 - simplywall.st

SMS Pharmaceuticals (NSE:SMSPHARMA) Has Announced A Dividend Of ₹0.40  simplywall.st

SMS Pharmaceuticals (NSE:SMSPHARMA) Has Announced A Dividend Of ₹0.40 - simplywall.st

Click here to get full coverage on NSE:SMSPHARMA Chartbild von VR_Securities - TradingView

NSE:SMSPHARMA Chartbild von VR_Securities  TradingView

NSE:SMSPHARMA Chartbild von VR_Securities - TradingView

Click here to get full coverage on Stocks to Watch Today: Lotus Developers, InterGlobe, SMS Pharma, E2E Networks, Mangal Electrical, HFCL,... - Moneycontrol.com

Stocks to Watch Today: Lotus Developers, InterGlobe, SMS Pharma, E2E Networks, Mangal Electrical, HFCL,...  Moneycontrol.com

Stocks to Watch Today: Lotus Developers, InterGlobe, SMS Pharma, E2E Networks, Mangal Electrical, HFCL,... - Moneycontrol.com

Click here to get full coverage on Sms Pharmaceuticals Stock Price Forecast. Should You Buy SMSPHARMA.NS? - StockInvest.us

Sms Pharmaceuticals Stock Price Forecast. Should You Buy SMSPHARMA.NS?  StockInvest.us

Sms Pharmaceuticals Stock Price Forecast. Should You Buy SMSPHARMA.NS? - StockInvest.us

Click here to get full coverage on SMS Pharmaceuticals Clears USFDA Inspection at Vizag API Facility With One Observation - India Infoline

SMS Pharmaceuticals Clears USFDA Inspection at Vizag API Facility With One Observation  India Infoline

SMS Pharmaceuticals Clears USFDA Inspection at Vizag API Facility With One Observation - India Infoline

Click here to get full coverage on SMSPHARMA Stock Price and Chart — NSE:SMSPHARMA - TradingView

SMSPHARMA Stock Price and Chart — NSE:SMSPHARMA  TradingView

SMSPHARMA Stock Price and Chart — NSE:SMSPHARMA - TradingView

Click here to get full coverage on SMS Pharma's Hyderabad Lab Receives FDA Clearance with 'No Action Indicated' Status - scanx.trade

SMS Pharma's Hyderabad Lab Receives FDA Clearance with 'No Action Indicated' Status  scanx.trade

SMS Pharma's Hyderabad Lab Receives FDA Clearance with 'No Action Indicated' Status - scanx.trade

Click here to get full coverage on SMS Pharma Receives 'No Action Indicated' Status from USFDA for Hyderabad Laboratory - scanx.trade

SMS Pharma Receives 'No Action Indicated' Status from USFDA for Hyderabad Laboratory  scanx.trade

SMS Pharma Receives 'No Action Indicated' Status from USFDA for Hyderabad Laboratory - scanx.trade

Click here to get full coverage on Trade Spotlight: How should you trade Lupin, IIFL Finance, Max Financial Services, Adani Ports, SMS... - Moneycontrol.com

Trade Spotlight: How should you trade Lupin, IIFL Finance, Max Financial Services, Adani Ports, SMS...  Moneycontrol.com

Trade Spotlight: How should you trade Lupin, IIFL Finance, Max Financial Services, Adani Ports, SMS... - Moneycontrol.com

Click here to get full coverage on Technical Analysis of SMS Pharmaceuticals Limited (NSE:SMSPHARMA) - TradingView

Technical Analysis of SMS Pharmaceuticals Limited (NSE:SMSPHARMA)  TradingView

Technical Analysis of SMS Pharmaceuticals Limited (NSE:SMSPHARMA) - TradingView

Click here to get full coverage on SMS Pharmaceuticals Gets USFDA Clearance for Hyderabad Lab With NAI Status - India Infoline

SMS Pharmaceuticals Gets USFDA Clearance for Hyderabad Lab With NAI Status  India Infoline

SMS Pharmaceuticals Gets USFDA Clearance for Hyderabad Lab With NAI Status - India Infoline

Click here to get full coverage on SMS Pharma receives EDQM certification to supply Ibuprofen in Europe - Indian Pharma Post

SMS Pharma receives EDQM certification to supply Ibuprofen in Europe  Indian Pharma Post

SMS Pharma receives EDQM certification to supply Ibuprofen in Europe - Indian Pharma Post

Click here to get full coverage on SMS Pharmaceuticals clears USFDA inspection at Vizag API plant with one minor observation - CNBC TV18

SMS Pharmaceuticals clears USFDA inspection at Vizag API plant with one minor observation  CNBC TV18

SMS Pharmaceuticals clears USFDA inspection at Vizag API plant with one minor observation - CNBC TV18

Click here to get full coverage on SMS Pharma successfully completes USFDA inspection at Telangana Central Laboratory Analytical Services - Medical Dialogues

SMS Pharma successfully completes USFDA inspection at Telangana Central Laboratory Analytical Services  Medical Dialogues

SMS Pharma successfully completes USFDA inspection at Telangana Central Laboratory Analytical Services - Medical Dialogues

Click here to get full coverage on SMS Pharma revenue down 9% - Indian Pharma Post

SMS Pharma revenue down 9%  Indian Pharma Post

SMS Pharma revenue down 9% - Indian Pharma Post

Click here to get full coverage on SMS Pharma Visakhapatnam facility gets WHO Geneva prequalification - Medical Dialogues

SMS Pharma Visakhapatnam facility gets WHO Geneva prequalification  Medical Dialogues

SMS Pharma Visakhapatnam facility gets WHO Geneva prequalification - Medical Dialogues

Click here to get full coverage on SMS Pharma gets one USFDA observation for Bachupally facility - Medical Dialogues

SMS Pharma gets one USFDA observation for Bachupally facility  Medical Dialogues

SMS Pharma gets one USFDA observation for Bachupally facility - Medical Dialogues

Click here to get full coverage on SMS PHARMACEUTICALS LTD. Share Price Today - Live SMSPHARMA Stock Price for NSE/BSE - Upstox

SMS PHARMACEUTICALS LTD. Share Price Today - Live SMSPHARMA Stock Price for NSE/BSE  Upstox

SMS PHARMACEUTICALS LTD. Share Price Today - Live SMSPHARMA Stock Price for NSE/BSE - Upstox

Click here to get full coverage on SMS Pharma reports on USFDA articulation on Ranitidine - Microbioz India

SMS Pharma reports on USFDA articulation on Ranitidine  Microbioz India

SMS Pharma reports on USFDA articulation on Ranitidine - Microbioz India

Click here to get full coverage on SMS Pharma gains 7%, increases stake in VKT Pharma - Moneycontrol.com

SMS Pharma gains 7%, increases stake in VKT Pharma  Moneycontrol.com

SMS Pharma gains 7%, increases stake in VKT Pharma - Moneycontrol.com

Click here to get full coverage on Stocks in news: SMS Pharma, Patel Engineering, Vedanta, HG Infra, SJVN - The Economic Times

Stocks in news: SMS Pharma, Patel Engineering, Vedanta, HG Infra, SJVN  The Economic Times

Stocks in news: SMS Pharma, Patel Engineering, Vedanta, HG Infra, SJVN - The Economic Times

Click here to get full coverage on SMS Pharma gets USFDA approval for Andhra unit - Medical Dialogues

SMS Pharma gets USFDA approval for Andhra unit  Medical Dialogues

SMS Pharma gets USFDA approval for Andhra unit - Medical Dialogues

Click here to get full coverage on SMS Pharma hits new high on USFDA nod for Andhra unit - Business Standard

SMS Pharma hits new high on USFDA nod for Andhra unit  Business Standard

SMS Pharma hits new high on USFDA nod for Andhra unit - Business Standard

Click here to get full coverage on SMS Pharma receives EIR for Bachupally facility - Equitypandit

SMS Pharma receives EIR for Bachupally facility  Equitypandit

SMS Pharma receives EIR for Bachupally facility - Equitypandit

Click here to get full coverage on SMS Pharma extends rally post stock split; hit new high - Business Standard

SMS Pharma extends rally post stock split; hit new high  Business Standard

SMS Pharma extends rally post stock split; hit new high - Business Standard

Click here to get full coverage on SMS Pharma to take over Plant Organics - Business Standard

SMS Pharma to take over Plant Organics  Business Standard

SMS Pharma to take over Plant Organics - Business Standard

Click here to get full coverage on SMS Pharma to invest about Rs 1000 cr in AP - Business Standard

SMS Pharma to invest about Rs 1000 cr in AP  Business Standard

SMS Pharma to invest about Rs 1000 cr in AP - Business Standard

Click here to get full coverage on SMS Pharma to acquire Plant Organics - livemint.com

SMS Pharma to acquire Plant Organics  livemint.com

SMS Pharma to acquire Plant Organics - livemint.com

Click here to get full coverage on SMS Pharmaceuticals shares soar 17% after USFDA approves reformulated Ranitidine tablets - livemint.com

SMS Pharmaceuticals shares soar 17% after USFDA approves reformulated Ranitidine tablets  livemint.com

SMSPHARMA

Price Chart

Key Statistics

Technicals

About SMSPHARMA

Latest News

Enterprise value to revenue forward of SMS Pharmaceuticals Limited – NSE:SMSPHARMA - TradingView

SMS Pharmaceuticals' (NSE:SMSPHARMA) Earnings Are Of Questionable Quality - simplywall.st

SMS Pharma Q4 Net Profit Climbs to ₹20.9 Cr with 1.4% YoY Growth - Sahi

Advanced Charts

Top Gainers

Top Losers